Keros Therapeutics
KROS
KROS
88 hedge funds and large institutions have $545M invested in Keros Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $599M → $545M (-$54M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
88
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$7.43M | |
2 | +$6.85M | |
3 | +$6.39M | |
4 |
Citadel Advisors
Miami,
Florida
|
+$6.19M |
5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.74M |
Top Sellers
1 | -$37.7M | |
2 | -$18.2M | |
3 | -$11.6M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10M |
5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$4.42M |